Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism

BACKGROUND: Dabigatran etexilate (DE), a direct oral thrombin inhibitor, has been evaluated in children with venous thromboembolism (VTE) using oral solution, pellets, or capsules. OBJECTIVES: This study evaluated DE pharmacokinetics (PK) in children with VTE and the appropriateness of a DE pediatri...

Descripción completa

Detalles Bibliográficos
Autores principales: Röshammar, Daniel, Huang, Fenglei, Albisetti, Manuela, Bomgaars, Lisa, Chalmers, Elizabeth, Luciani, Matteo, Halton, Jacqueline, Mitchell, Lesley G., Bergstrand, Martin, Ibrahim, Moustafa M. A., Joseph, David, Tartakovsky, Igor, Gropper, Savion, Brueckmann, Martina, Brandão, Leonardo R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
THROMBOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251571/
https://www.ncbi.nlm.nih.gov/pubmed/33636042
http://dx.doi.org/10.1111/jth.15277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251571/
https://www.ncbi.nlm.nih.gov/pubmed/33636042
http://dx.doi.org/10.1111/jth.15277

Ejemplares similares